Two ETH bulls are still actively building positions, purchasing $17.51 million and $8.17 million respectively.

Amylyx Pharmaceuticals announced that its current cash reserves are expected to be sufficient to support the company's operations, not only covering the potential commercialization process of the new drug Avexitide, but also sustaining operations through 2028.

Industrial giant Honeywell has officially filed a Form 10 registration statement with the U.S. Securities and Exchange Commission, marking a key milestone in the planned spin-off of its aerospace business unit.

Passage Bio is actively advancing its differentiated preclinical research project for Huntington's disease.

Consumer electronics retail giant Best Buy announced that its board of directors has officially approved a resolution to slightly increase the regular quarterly cash dividend by 1%, reaching $0.96 per share.